Intraoperative methadone alters 72-hour postoperative morphine use after hip fracture surgery in older adults
This randomized trial compared a single intraoperative dose of methadone (0.10 mg/kg) with placebo in 129 patients aged 60 years or older undergoing hip fracture surgery. The primary outcome was postoperative morphine consumption, measured in 24-hour intervals over 72 hours. Secondary outcomes included pain scores, time to mobilization, time to discharge, and adverse and serious adverse events.
Postoperative morphine consumption over 72 hours differed significantly between groups by likelihood-ratio test (P = 0.02). Model-based estimates indicated lower morphine consumption with methadone at 0-24 hours (LSM 7.1 [SE 1.2] vs 10.1 [SE 1.7] mg) and at 24-48 hours (4.1 [SE 0.8] vs 5.3 [SE 0.9] mg). In the 48-72 hour window, the model suggested lower morphine consumption in the placebo group (3.2 [SE 0.6] vs methadone 4.6 [SE 0.9] mg), so the overall effect was a redistribution rather than a uniform reduction across the full 72 hours.
Most secondary outcomes were similar between groups, except for time to hospital discharge, which was longer with methadone (LSM 5.6 vs 4.5 days; mean difference -1.3 days, 95% CI -2.3 to -0.4; P < 0.01). Harms appeared comparable, but the low event rate precluded formal analysis, so specific adverse event rates and discontinuations were not reported in the abstract.
The authors conclude that a single intraoperative dose of methadone significantly alters postoperative morphine consumption over 72 hours after hip fracture surgery without major safety concerns. Clinicians weighing this approach should consider the front-loaded opioid-sparing effect against the signal for longer hospital stay and the limited power to characterize harms.